Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$25.46 - $37.72 $1.74 Million - $2.58 Million
-68,358 Reduced 21.52%
249,318 $9.3 Million
Q1 2022

May 16, 2022

SELL
$18.94 - $34.29 $7.47 Million - $13.5 Million
-394,275 Reduced 55.38%
317,676 $9.5 Million
Q4 2021

Feb 14, 2022

BUY
$27.58 - $40.0 $2.03 Million - $2.95 Million
73,746 Added 11.56%
711,951 $24.4 Million
Q3 2021

Nov 15, 2021

BUY
$27.98 - $40.0 $4.58 Million - $6.55 Million
163,651 Added 34.49%
638,205 $23.7 Million
Q2 2021

Aug 16, 2021

BUY
$32.22 - $41.5 $5.6 Million - $7.21 Million
173,683 Added 57.73%
474,554 $18.5 Million
Q1 2021

May 17, 2021

BUY
$36.3 - $56.34 $10.9 Million - $17 Million
300,871 New
300,871 $12.8 Million

Others Institutions Holding IMCR

About Immunocore Holdings plc


  • Ticker IMCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,897,100
  • Market Cap $1.24B
  • Description
  • Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...
More about IMCR
Track This Portfolio

Track Bain Capital Public Equity Management Ii, LLC Portfolio

Follow Bain Capital Public Equity Management Ii, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bain Capital Public Equity Management Ii, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bain Capital Public Equity Management Ii, LLC with notifications on news.